• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock (NQ:XOMAP)

24.98 UNCHANGED
Last Price Updated: 3:06 PM EDT, Jul 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 24.98
Bid (Size) 24.87 (200)
Ask (Size) 48.95 (100)
Prev. Close 24.98
Today's Range 24.98 - 24.98
52wk Range 24.93 - 27.30
Shares Outstanding N/A
Dividend Yield 8.63%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
XOMA Royalty Announces Closing of Its Acquisition by Ligand
July 14, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
June 12, 2026
From XOMA Royalty Corporation
Via GlobeNewswire

Performance

52-Week Range 8.5% below 52-week high
24.98
24.9352W Low 27.3052W High

XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock (XOMAP) traded between $24.93 and $27.30 over the past 52 weeks and last traded at $24.98, 8.5% below its 52-week high.

Past 12 Months
N/A
N/A
N/A
-1.1%
-7.9%
-6.0%
1W  
1M  
3M  
6M -$0.27
YTD -$2.13
1Y -$1.60

XOMAP was -6.0% over the past year, -1.1% over six months, -7.9% year to date.

12 Months vs Market
XOMAP
-6.0%
DIA
+10.4%
SPY
+12.2%
QQQ
+14.1%
IWM
+10.6%

Over the past 12 months XOMAP returned -6.0% versus DIA (Dow) +10.4%, SPY (S&P 500) +12.2%, QQQ (Nasdaq 100) +14.1% and IWM (Russell 2000) +10.6%.

Volume & Liquidity
6M
3.4K
YTD
2.0K
1Y
1.8K

More News

Read More
XOMA ROYALTY CORP (NASDAQ:XOMAP) Passes Navellier’s Little Book Growth Screen with Strong Momentum ↗
May 14, 2026
Via Chartmill
News headline image
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
April 27, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
XOMA ROYALTY CORP - XOMA 8 5/8 PERP (NASDAQ:XOMAP) Shines in Growth Screen from Navellier's 'Little Book That Makes You Rich' ↗
April 22, 2026
Via Chartmill
XOMA Royalty Corp (NASDAQ:XOMAP) Screened as a High-Growth Stock Using Navellier's Strategy ↗
March 31, 2026
Via Chartmill
News headline image
XOMA Royalty Declares Quarterly Preferred Stock Dividends
March 18, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
March 18, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
March 12, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty to Present at Investor Conferences in March
February 18, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
February 09, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces CFO Transition
January 12, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
December 30, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Declares Quarterly Preferred Stock Dividends
December 22, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
December 05, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
November 21, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
November 12, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
October 17, 2025
From XOMA Royalty Corporation; LAVA Therapeutics N.V.
Via GlobeNewswire
News headline image
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
October 02, 2025
From XOMA Royalty Corporation; LAVA Therapeutics
Via GlobeNewswire
News headline image
XOMA Royalty Declares Quarterly Preferred Stock Dividends
September 22, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
September 17, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
August 20, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
August 13, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics
August 11, 2025
From XOMA Royalty Corporation
Via GlobeNewswire

Frequently Asked Questions

Is XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock publicly traded?
Yes, XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock is publicly traded.
What exchange does XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock trade on?
XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock trades on the Nasdaq Stock Market
What is the ticker symbol for XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock?
The ticker symbol for XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock is XOMAP on the Nasdaq Stock Market
What is the current price of XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock?
The current price of XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock is 24.98
When was XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock last traded?
The last trade of XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock was at 07/13/26 03:06 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap